Author Archive: Scott Frotman

Scott Frotman

Scott Frotman is director, communications and executive writer for BIO. The best part of his job is getting to tell the story of exciting emerging biotechnology companies that are transforming our economy and our society. Prior to joining BIO, Scott was the senior speechwriter at the U.S. Small Business Administration (SBA) and the Export-Import Bank of the United States. Scott also served as communications director for Congressman Luis V. Gutierrez and held communications positions at Deloitte & Touche, Tribune Company and the United Food and Commercial Workers International Union. When not working, Scott recently decided to take up tennis after a 20-year hiatus. The results have not been promising. On weekends, Scott can usually be found losing badly to players of all levels and all ages.

Latest Posts

WSJ: U.S. Concessions on TPP Means Fewer Cures

Seal of the President of the U.S.

Today’s Wall Street Journal editorial, Pacific Trade Brinksmanship, does an outstanding job highlighting the important role that patent protection plays in promoting innovation and fostering medical breakthroughs. The article highlights why adequate protections for biologics must be a centerpiece of a successful Trans-Pacific Partnership (TPP). One of the issues being negotiated is the right amount of patent protection for innovative medicines. As the editorial notes, the U.S. currently wants “biologic protections to last a dozen Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Producing “21st Century Cures” – 2015 U.S. Legislative Outlook with Chairman Upton and Rep. DeGette

21st Century Cures Act

BIO President & CEO Jim Greenwood today sat down with Energy & Commerce Committee Chairman Fred Upton (R-MI) and Congresswoman Diana DeGette (D-CO) for a lively and in-depth discussion of the 21st Century Cures Initiative, a comprehensive effort to accelerate the discovery, development and delivery of new drugs and therapies. The conversation was a great way to kick off the opening plenary of the 17th BIO CEO & Investor Conference. This year’s conference, as Greenwood noted, has a Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Greenwood Highlights Need for Bold Action to Address Alzheimer’s

Jim Greenwood

Last week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), participated and spoke at the #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit hosted at the United Nations in New York City. The day-long event explored links between Traumatic Brain Injury and Alzheimer’s Disease and featured leading policy experts, biotechnology entrepreneurs, academics,  investment firms, medical researchers, diplomats and professional athletes. The event was hosted by Brewer Sports International (BSI), a multi-faceted global Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

DuPont’s CEO receives George Washington Carver Award at BIO World Congress

WC-Carver-Award-115x76

Yesterday, Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, presented Ellen Kullman, CEO and Chair of the Board of DuPont, with the 2014 George Washington Carver Award, one of industrial biotechnology’s highest honors. The award ceremony took place during the opening day of the 2014 BIO World Congress on Industrial Biotechnology in Philadelphia, PA. The George Washington Carver Award was created to recognize significant contributions by individuals advancing innovation in the field of Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO CEO Lays out Vision for Future of Industrial Biotech

Jim Greenwood

During the opening plenary lunch at BIO’s World Congress on Industrial Biotechnology, Jim Greenwood, President and CEO of BIO, laid out a comprehensive state of the industry to a packed room of entrepreneurs, scientists, investors and business leaders from more than 35 countries. In his remarks, Greenwood talked about the important strides the industry has made. “Cellulosic and advanced biofuel companies are at a pivotal point in commercial development,” Greenwood said.  “In addition, we are Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,